Long-Lasting Ventricular Fibrillation in Humans ECG Characteristics and Effect of Radiofrequency Ablation.


Journal

Circulation. Arrhythmia and electrophysiology
ISSN: 1941-3084
Titre abrégé: Circ Arrhythm Electrophysiol
Pays: United States
ID NLM: 101474365

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 12 9 2020
medline: 16 3 2021
entrez: 11 9 2020
Statut: ppublish

Résumé

Studies of ventricular fibrillation (VF) in humans are limited because of the short available duration. We sought to study surface ECG waveforms and effect of ablation in long-lasting VF in patients with left assist devices. Continuous 12-lead ECG of 5 episodes of long-lasting VF occurring in 3 patients with left ventricular assist device were analyzed. Spectral analysis (dominant frequency) and quantification of waveform amplitude, regularity (Unbiased Regularity Index), and complexity (Nondipolar Index) were performed over a median of 24 minutes of VF. Radiofrequency ablation was performed during VF in 2 patients. There was a significant increase in dominant frequency between VF onset and termination but none of the other parameters significantly changed. Some VF parameters varied from patient to patient and from lead to lead. Dominant frequency decreased after radiofrequency ablation in both cases and VF terminated spontaneously shortly after ablation in one case. The previously incessant VFs in these 2 patients did not recur afterward. VF rate increases over time in patients with left ventricular assist devices and is lowered by ablation. Long-lasting VF may be modified or even terminated by ablation.

Sections du résumé

BACKGROUND
Studies of ventricular fibrillation (VF) in humans are limited because of the short available duration. We sought to study surface ECG waveforms and effect of ablation in long-lasting VF in patients with left assist devices.
METHODS
Continuous 12-lead ECG of 5 episodes of long-lasting VF occurring in 3 patients with left ventricular assist device were analyzed. Spectral analysis (dominant frequency) and quantification of waveform amplitude, regularity (Unbiased Regularity Index), and complexity (Nondipolar Index) were performed over a median of 24 minutes of VF. Radiofrequency ablation was performed during VF in 2 patients.
RESULTS
There was a significant increase in dominant frequency between VF onset and termination but none of the other parameters significantly changed. Some VF parameters varied from patient to patient and from lead to lead. Dominant frequency decreased after radiofrequency ablation in both cases and VF terminated spontaneously shortly after ablation in one case. The previously incessant VFs in these 2 patients did not recur afterward.
CONCLUSIONS
VF rate increases over time in patients with left ventricular assist devices and is lowered by ablation. Long-lasting VF may be modified or even terminated by ablation.

Identifiants

pubmed: 32911973
doi: 10.1161/CIRCEP.120.008639
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e008639

Auteurs

Philippe Maury (P)

Department of Cardiology, University Hospital Rangueil, Toulouse, France (P.M., A.R., Q.V.-S., B.M., P.M., C.D.).
Unité Inserm U 1048, Toulouse, France (P.M.).

Josselin Duchateau (J)

Bordeaux University Hospital, France (J.D., M. Hocini, F.S., P.J., M. Haïssaguerre).
LIRYC Institute/INSERM 1045, Bordeaux University, France (J.D., M. Hocini, F.S., P.J., O.B., M. Haïssaguerre, R.D.).

Anne Rollin (A)

Department of Cardiology, University Hospital Rangueil, Toulouse, France (P.M., A.R., Q.V.-S., B.M., P.M., C.D.).

Meleze Hocini (M)

Bordeaux University Hospital, France (J.D., M. Hocini, F.S., P.J., M. Haïssaguerre).
LIRYC Institute/INSERM 1045, Bordeaux University, France (J.D., M. Hocini, F.S., P.J., O.B., M. Haïssaguerre, R.D.).

Quentin Voglimacci-Stephanopoli (Q)

Department of Cardiology, University Hospital Rangueil, Toulouse, France (P.M., A.R., Q.V.-S., B.M., P.M., C.D.).

Benjamin Monteil (B)

Department of Cardiology, University Hospital Rangueil, Toulouse, France (P.M., A.R., Q.V.-S., B.M., P.M., C.D.).

Frederic Sacher (F)

Bordeaux University Hospital, France (J.D., M. Hocini, F.S., P.J., M. Haïssaguerre).
LIRYC Institute/INSERM 1045, Bordeaux University, France (J.D., M. Hocini, F.S., P.J., O.B., M. Haïssaguerre, R.D.).

Pierre Jaïs (P)

Bordeaux University Hospital, France (J.D., M. Hocini, F.S., P.J., M. Haïssaguerre).
LIRYC Institute/INSERM 1045, Bordeaux University, France (J.D., M. Hocini, F.S., P.J., O.B., M. Haïssaguerre, R.D.).

Olivier Bernus (O)

LIRYC Institute/INSERM 1045, Bordeaux University, France (J.D., M. Hocini, F.S., P.J., O.B., M. Haïssaguerre, R.D.).

Pierre Mondoly (P)

Department of Cardiology, University Hospital Rangueil, Toulouse, France (P.M., A.R., Q.V.-S., B.M., P.M., C.D.).

Clément Delmas (C)

Department of Cardiology, University Hospital Rangueil, Toulouse, France (P.M., A.R., Q.V.-S., B.M., P.M., C.D.).

Michel Haïssaguerre (M)

Bordeaux University Hospital, France (J.D., M. Hocini, F.S., P.J., M. Haïssaguerre).
LIRYC Institute/INSERM 1045, Bordeaux University, France (J.D., M. Hocini, F.S., P.J., O.B., M. Haïssaguerre, R.D.).

Rémi Dubois (R)

LIRYC Institute/INSERM 1045, Bordeaux University, France (J.D., M. Hocini, F.S., P.J., O.B., M. Haïssaguerre, R.D.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH